Toxicology Reagent CEDIA® Opiates (OPI) CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Toxicology Reagent
Brand: CEDIA®

REAGENT, IMMUNOASSAY CEDIA OPIATE 3X17ML D/S

McKesson #

1254929

Manufacturer #

100098

Brand

CEDIA®

Manufacturer

Fisher Scientific

Country of Origin

Unknown

Application

Toxicology Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Urine Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Method

Homogenous Enzyme Immunoassay (HEIA)

Test Name

Opiates (OPI)

Test Type

Single Drug

UNSPSC Code

41116007

Volume

3 X 17 mL

The CEDIA Opiate Assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative assay of opiates in human urine
The CEDIA Opiate assay uses recombinant DNA technology (US Patent No. 4708929) to produce a unique homogeneous enzyme immunoassay system
Qualitative or semi-quantitative options for results
Excellent correlation to GC/MS